Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Baxter International Inc.
Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $11.68B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.49 | 0.92%
Avg Daily Range (30 D): $0.32 | 1.40%
Avg Daily Range (90 D): $0.37 | 1.46%
Institutional Daily Volume
Avg Daily Volume: 3.36M
Avg Daily Volume (30 D): 4.74M
Avg Daily Volume (90 D): 5.38M
Trade Size
Avg Trade Size (Sh.): 149
Avg Trade Size (Sh.) (30 D): 95
Avg Trade Size (Sh.) (90 D): 104
Institutional Trades
Total Inst.Trades: 62,496
Avg Inst. Trade: $3.82M
Avg Inst. Trade (30 D): $4.86M
Avg Inst. Trade (90 D): $4.59M
Avg Inst. Trade Volume: .07M
Avg Inst. Trades (Per Day): 11
Market Closing Trades
Avg Closing Trade: $20.18M
Avg Closing Trade (30 D): $21.82M
Avg Closing Trade (90 D): $22.57M
Avg Closing Volume: 369.3K
   
News
Oct 21, 2025 @ 4:57 PM
BAXTER INTERNATIONAL INC. (NYSE: BAX) INVESTOR ALE...
Source: Bernstein Liebhard Llp
Oct 20, 2025 @ 7:45 PM
BAX CLASS ACTION LAWSUIT: Baxter International Inc...
Source: Bleichmar Fonti & Auld Llp
Oct 20, 2025 @ 6:40 PM
BAX Investor Notice: Robbins LLP Reminds Stockhold...
Source: Robbins Llp
Oct 19, 2025 @ 4:00 PM
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman ...
Source: Bronstein, Gewirtz & Grossman Llc
Oct 19, 2025 @ 12:17 AM
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Bax...
Source: Rosen Law Firm
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $.18 $.25
Diluted EPS $.18 $.25
Revenue $ $ 2.81B $ 2.63B
Gross Profit $ $ 991M $ 861M
Net Income / Loss $ $ 91M $ 126M
Operating Income / Loss $ $ 191M $ 58M
Cost of Revenue $ $ 1.82B $ 1.76B
Net Cash Flow $ $ -608M $ -118M
PE Ratio    
Splits
May 31, 2001:   2:1